Trimetazidine is indicated in adults as add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled by or intolerant to first-line antianginal therapies.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education